169 related articles for article (PubMed ID: 37630292)
1. Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
Meier JP; Zhang HJ; Freifelder R; Bhuiyan M; Selman P; Mendez M; Kankanamalage PHA; Brossard T; Pusateri A; Tsai HM; Leoni L; Penano S; Ghosh K; Broder BA; Markiewicz E; Renne A; Stadler W; Weichselbaum R; Nolen J; Kao CM; Chitneni SK; Rotsch DA; Szmulewitz RZ; Chen CT
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630292
[TBL] [Abstract][Full Text] [Related]
2. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
3. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract][Full Text] [Related]
4. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, radiolabeling, and pre-clinical evaluation of [
Ghiani S; Hawala I; Szikra D; Trencsényi G; Baranyai Z; Nagy G; Vágner A; Stefania R; Pandey S; Maiocchi A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2351-2362. PubMed ID: 33420915
[TBL] [Abstract][Full Text] [Related]
6.
Dellepiane G; Casolaro P; Mateu I; Scampoli P; Voeten N; Braccini S
Appl Radiat Isot; 2022 Nov; 189():110428. PubMed ID: 36049443
[TBL] [Abstract][Full Text] [Related]
7. First In Vivo and Phantom Imaging of Cyclotron-Produced
Nelson BJB; Ferguson S; Wuest M; Wilson J; Duke MJM; Richter S; Soenke-Jans H; Andersson JD; Juengling F; Wuest F
J Nucl Med; 2022 Apr; 63(4):584-590. PubMed ID: 34385334
[TBL] [Abstract][Full Text] [Related]
8. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
[TBL] [Abstract][Full Text] [Related]
9. Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47.
Chernysheva M; Loveless SC; Brossard T; Becker K; Cingoranelli S; Aluicio-Sarduy E; Song J; Ellison P; Nolen J; Rotsch DA; Lapi SE; Engle JW
Curr Radiopharm; 2021; 14(4):359-373. PubMed ID: 33438551
[TBL] [Abstract][Full Text] [Related]
10. Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept.
Huclier-Markai S; Alliot C; Kerdjoudj R; Mougin-Degraef M; Chouin N; Haddad F
Cancer Biother Radiopharm; 2018 Oct; 33(8):316-329. PubMed ID: 30265573
[TBL] [Abstract][Full Text] [Related]
11.
Sinnes JP; Bauder-Wüst U; Schäfer M; Moon ES; Kopka K; Rösch F
EJNMMI Radiopharm Chem; 2020 Nov; 5(1):28. PubMed ID: 33242189
[TBL] [Abstract][Full Text] [Related]
12. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
13.
Dellepiane G; Casolaro P; Gottstein A; Mateu I; Scampoli P; Braccini S
Appl Radiat Isot; 2024 Apr; 206():111220. PubMed ID: 38301319
[No Abstract] [Full Text] [Related]
14. Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for
Kelly JM; Ponnala S; Amor-Coarasa A; Zia NA; Nikolopoulou A; Williams C; Schlyer DJ; DiMagno SG; Donnelly PS; Babich JW
Mol Pharm; 2020 Jun; 17(6):1954-1962. PubMed ID: 32286841
[TBL] [Abstract][Full Text] [Related]
15. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of
Vaughn BA; Loveless CS; Cingoranelli SJ; Schlyer D; Lapi SE; Boros E
Mol Pharm; 2021 Dec; 18(12):4511-4519. PubMed ID: 34714082
[TBL] [Abstract][Full Text] [Related]
17. Developments toward the Implementation of
van der Meulen NP; Hasler R; Talip Z; Grundler PV; Favaretto C; Umbricht CA; Müller C; Dellepiane G; Carzaniga TS; Braccini S
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066650
[No Abstract] [Full Text] [Related]
18. Promising prospects for 44Sc-/47Sc-based theragnostics: application of 47Sc for radionuclide tumor therapy in mice.
Müller C; Bunka M; Haller S; Köster U; Groehn V; Bernhardt P; van der Meulen N; Türler A; Schibli R
J Nucl Med; 2014 Oct; 55(10):1658-64. PubMed ID: 25034091
[TBL] [Abstract][Full Text] [Related]
19. Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets.
Loveless CS; Blanco JR; Diehl GL; Elbahrawi RT; Carzaniga TS; Braccini S; Lapi SE
J Nucl Med; 2021 Jan; 62(1):131-136. PubMed ID: 32620699
[TBL] [Abstract][Full Text] [Related]
20. (44)Sc: an attractive isotope for peptide-based PET imaging.
Hernandez R; Valdovinos HF; Yang Y; Chakravarty R; Hong H; Barnhart TE; Cai W
Mol Pharm; 2014 Aug; 11(8):2954-61. PubMed ID: 25054618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
